Instructions
Please read this page carefully. You will need to scroll down this page and ensure that you have read the learning objectives, accreditation information, and potential conflicts of interest disclosures for the authoring faculty. Please check the box to agree to the terms of understanding and click the "Start Module" button on the bottom of the page to begin your learning activity.

Learning Objectives
As a result of participating and interacting in this activity, participants will be better able to:

• Clarify the current standard treatment algorithm for a patient with previously well controlled bipolar disorder who becomes depressed on medication and discuss potential causes for breakthrough
• Evaluate available psychopharmacologic therapy options which would be appropriate in various bipolar disease scenarios along the continuum of care
• Describe the potential side effects of mood enhancing agents in individuals diagnosed with bipolar disorder and review options for managing these events

Accreditation
This learning activity has been designated for 1.75 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in this activity.
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Target Audience
This learning activity is intended for a broad audience of healthcare practitioners, including primary care physicians, family physicians, emergency medicine physicians, psychiatrists, psychologists, nurse practitioners, and physician assistants or other healthcare professionals with an interest in treating patients with Bipolar Disorder.

Disclosure Statements
To view the Disclosure Statements, please click here.